Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
Key facts
- Who runs it
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Jan 2024
- Ended
- 30 Jun 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- PCR - Immunohistochemistry - Immunolabelling
- Record updated
- 20 August 2026
- Why it stopped
- Feasibility issue
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patient with oropharyngeal squamous cell carcinoma or the oral cavity histologically proven
- Primary tumor for which a biopsy or excision is required available and sufficient to carry out molecular analysis
Who cannot take part
- Patient with Head and Neck cancer other than oropharyngeal or oral cavity squamous cells carcinomas
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Squamous cell cancers of the head and neck are classically correlated to excessive consumption of alcohol and tobacco and have a rather poor prognosis. However, the incidence of Head and Neck cancers in patients without alcohol-smoking risk factor has continued to increase in recent years, in relation to more and more frequent HPV contamination.
Read full original descriptionShow less
Some studies show a difference in the expression of certain genes within the two groups of tumors (HPV+ and HPV-) including some that confer sensitivity to certain chemotherapies and others to radiotherapy. However, patients with HPV+ Head and Neck cancers are treated according to the same referential as HPV- Head and Neck cancers. There is therefore a real need for studies identifying predictive markers in order to be able to offer patients a more effective suitable and less invasive treatment.
The 2 groups in the trial
- HPV + Group
Patients with positive HPV diagnosis
Treatment: PCR - Immunohistochemistry - Immunolabelling
- HPV - Group
Patients with negative HPV diagnosis
Treatment: PCR - Immunohistochemistry - Immunolabelling
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Genomic Alterations and Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
- Record updated
- 20 August 2026